Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b

Douglas Goodin, Anthony Reder, Anthony Traboulsee, David Li, Dawn Langdon, Gary Cutter, Stuart Cook, Timothy O'Donnell, Marcelo Kremenchutzky, Joel Oger, Ralf Koelbach, Christoph Pohl, Eva-Maria Wicklein

Research output: Contribution to journalArticlepeer-review

134 Downloads (Pure)
Original languageEnglish
Pages (from-to)837-847
Number of pages11
JournalMultiple Sclerosis
Issue number6
Early online date15 May 2018
Publication statusPublished - 1 May 2019

Cite this